Clinical trial
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid…
NCT00003790 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003790 |
|---|---|
| Title | Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome |
| Official title | Detection of Minimal Residual Disease in Children Receiving Therapy for AML or MDS |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Leukemia, Myelodysplastic Syndromes |
| Intervention type | Genetic, Other |
| Interventions | polymerase chain reaction, flow cytometry |
| Enrollment | 496 |
| Start date | Feb 1, 1995 |
| Primary completion | Apr 1, 2002 |
| Completion | Sep 1, 2006 |
| First posted | Apr 23, 2004 |
| Last update posted | Aug 6, 2014 |
| Countries | Australia, Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: